List of insiders holdings for Adverum Biotechnologies Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
Versant Ventures IV LLC
Versant Venture Capital IV L.P.
Versant IV Luxco S.a r.l.
Versant Capital IV (Switzerland) GmbH
10% Owner
2020-12-23 17:17:285,003,892
0
5,003,892Form 13D
Zygtech LLC
10% Owner
2015-04-15 17:25:582,438,176
0
2,438,176Form 4
Venrock Associates VI L.P.
Venrock Partners VI L.P.
Venrock Management VI LLC
Venrock Partners Management VI LLC
VENROCK HEALTHCARE CAPITAL PARTNERS LP
VHCP Co-Investment Holdings LLC
VHCP Management LLC
Hove Anders D
Koh Bong Y
10% Owner
2014-08-07 15:17:110
2,365,471
2,365,471Form 4
Venrock Associates VI L.P.
Venrock Partners VI L.P.
Venrock Management VI LLC
Venrock Partners Management VI LLC
VENROCK HEALTHCARE CAPITAL PARTNERS LP
VHCP Co-Investment Holdings LLC
VHCP Management LLC
ROBERTS BRYAN E
Hove Anders D
10% Owner
2014-07-30 16:29:460
1,965,471
1,965,471Form 3
REGENERON PHARMACEUTICALS INC
10% Owner
2022-02-11 16:07:291,809,098
0
1,809,098Form 13G
Venrock Healthcare Capital Partners II L.P.
VHCP Co-Investment Holdings II LLC
VHCP Management II LLC
10% Owner
2015-02-13 16:41:381,382,735
0
1,382,735Form 13G
Chalberg Thomas W.
Chief Executive Officer
2015-06-11 18:21:39258,988
840,413
1,099,401Form 4
Russo Carlo
EVP and Chief Medical Officer
2016-05-13 17:48:19781,991
0
781,991Form 4
Fischer Laurent
CEO President and Director
2022-09-21 19:57:28727,380
0
727,380Form 4
Blumenkranz Mark S.
Director
2016-02-17 17:37:21543,227
31,593
574,820Form 4
Salzman Amber
President and CEO
2018-02-20 19:15:32478,000
0
478,000Form 4
Schwartz Steven Daniel
Director
2017-06-14 19:07:11432,593
0
432,593Form 4
DeRespino Christopher
See Remarks
2021-06-29 18:53:32425,000
0
425,000Form 3
Soparkar Peter
See Remarks section
2022-09-21 19:59:45273,251
0
273,251Form 4
Thedinga Angela
Chief Technology Officer
2021-08-10 21:25:16270,000
0
270,000Form 4
Barone Samuel B.
SVP Clinical Development
2017-02-13 17:35:56256,335
0
256,335Form 4
Rubio Roman G.
SVP Translational Medicine
2016-02-17 17:31:11240,650
0
240,650Form 4
PATTERSON LEONE D
President and CFO
2021-02-18 21:03:54240,000
0
240,000Form 4
GUERIN JOHN PATRICK
Director
10% Owner
2015-06-11 21:09:040
200,000
200,000Form 4
Clark Julie
Chief Medical Officer
2021-10-04 17:36:15164,723
0
164,723Form 4
Braun Shirley
VP Human Resources
2016-02-17 17:26:09161,140
0
161,140Form 4
Countouriotis Athena
SVP Chief Medical Officer
2018-02-20 19:16:22160,000
0
160,000Form 4
Osborne Aaron
Chief Medical Officer
2021-02-18 21:04:39150,000
0
150,000Form 4
Hull Hans
Chief Executive Officer
2015-08-25 17:09:21137,210
0
137,210Form 4
Leung Thomas
Chief Financial Officer
2020-02-21 19:17:15120,000
0
120,000Form 4
Riley Brigit
Chief Scientific Officer
2022-09-21 19:58:15118,734
0
118,734Form 4
Rakow John
SVP Genl Counsel Acting CFO
2022-09-16 19:00:02118,070
0
118,070Form 4
Swartzburg Michael
Principal Accounting Officer
2016-02-17 17:28:2482,113
0
82,113Form 4
Ozden Rabia Gurses
Director
2022-03-18 17:12:1780,000
0
80,000Form 4
Hong Soo
Director
2022-03-18 17:15:3380,000
0
80,000Form 4
Cheng Jennifer C.
General Counsel
2019-02-19 16:17:5480,000
0
80,000Form 4
Wachter Paul
Director
2016-03-02 17:12:2431,951
37,161
69,112Form 4
Machado Patrick
Director
2022-06-14 16:19:3152,500
0
52,500Form 4
MCLAUGHLIN JOHN PETER
Director
2016-02-17 17:42:4222,238
26,560
48,798Form 4
Seyedkazemi Setareh
Chief Development Officer
2022-09-21 20:00:3347,875
0
47,875Form 4
Spivey Richard N.
Director
2019-08-02 16:26:5545,000
0
45,000Form 4
Bain Linda
Chief Financial Officer
2015-08-25 17:00:4941,930
0
41,930Form 4
Gasmi Mehdi
Director
2021-05-14 20:01:5940,000
0
40,000Form 4
Woiwode Thomas
Director
2021-05-14 20:05:3840,000
0
40,000Form 4
Whitcup Scott M
Director
2022-06-14 16:20:3240,000
0
40,000Form 4
Lupher Jr. Mark L.
Director
2022-06-14 16:21:1340,000
0
40,000Form 4
Scopa James Paul
Director
2022-06-14 16:22:0040,000
0
40,000Form 4
Svoronos Dawn
Director
2022-06-14 16:22:4840,000
0
40,000Form 4
Tuckson Reed Vaughn
Director
2022-06-14 16:23:4740,000
0
40,000Form 4
Beckman Richard
Chief Medical Officer
2022-09-21 20:01:2639,061
0
39,061Form 4
Cleveland Paul B
Director
2018-06-15 16:25:2435,000
0
35,000Form 4
Carter Eric G
Director
2020-06-25 17:44:1530,000
0
30,000Form 4
Hemrajani Rekha
Director
2020-06-25 17:45:0430,000
0
30,000Form 4
D'Souza Rupert
Chief Financial Officer
2022-05-17 18:28:4420,850
0
20,850Form 4
PECOTA NANCY E
Principal Accounting Officer
2022-06-07 19:11:360
0
0Form 3
THRIFT JACK ANTHONY
Interim CFO
2021-09-13 17:49:310
0
0Form 3
Finer Mitchell H.
Former Director
2019-10-25 16:05:560
0
0Form 4/A
Flynn James E
Deerfield Mgmt L.P.
Deerfield Special Situations Fund L.P.
Deerfield Special Situations International Master Fund L.P.
Deerfield Mgmt III L.P.
DEERFIELD MANAGEMENT CO
Deerfield Private Design Fund III L.P.
DEERFIELD PARTNERS LP
Deerfield International Master Fund L.P.
Possible Members of 10% Group
10% Owner
2016-02-16 08:25:360
0
0Form 13G
Rubinstein Linda M
Chief Financial Officer
2022-12-15 17:27:090
0
0Form 3